Rafeifadattis, K.F. et al. 2025. Empaglifozin In Type 2 Diabetes: From Mechanisms To Clinical Practice – A Comprehensive Review Of Monotherapy, Combinations, And Therapeutic Advantages. Jurnal Ners. 10, 1 (Nov. 2025), 182–195. DOI:https://doi.org/10.31004/jn.v10i1.51869.